Study tests ease of new Alzheimer's drug delivery method
NCT ID NCT07056309
Summary
This study tested how the body absorbs and processes an experimental Alzheimer's drug called remternetug when it's given in two different ways. Researchers compared giving the drug with an easy-to-use auto-injector versus a traditional prefilled syringe in 72 healthy volunteers. The main goal was to see if both methods deliver the drug into the bloodstream equally well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
-
QPS Missouri
Springfield, Missouri, 65802, United States
Conditions
Explore the condition pages connected to this study.